Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Canada’s main share index is set to extend its rally over the coming year as the likely rollout of a COVID-19 vaccine bolsters prospects for the economically sensitive financial and resource stocks that dominate the index, a Reuters poll found.

See also: Global stocks bull run to race on, spurred by cheap cash, vaccine hopes: poll

The median forecast in a survey of more than 20 portfolio managers and strategists was for the S&P/TSX Composite index to rise nearly 8% to 18,400 by the end of 2021. That was higher than the 18,000 forecast in August’s poll, and would surpass February’s record high of 17,970.51.

The index has rebounded from an eight-year low in March at 11,172.73.

Story continues below advertisement

“The run-up in stocks will likely not end in 2021 as (U.S.) stimulus likely comes early in the new year, vaccines start to get distributed in the second half of the year and most companies go back to normal in the latter part of 2021,” said Sadiq Adatia, chief investment officer at Sun Life Global Investments.

Investors are hoping for progress in Washington in talks to craft a new fiscal relief package, while the recent surge in global coronavirus cases has been offset by encouraging news from a number of major drugmakers on the effectiveness of their candidate vaccines.

When asked if their forecasts were based on recent vaccine progress, three quarters of the poll’s respondents said they were.

A vaccine rollout would “benefit Canada more than most countries because of the large proportion of value and cyclical stocks on the TSX,” said Matt Skipp, president of SW8 Asset Management.

Cyclical stocks tend to be sensitive to the economic cycle. They include financial and resource stocks, which account for more than 50% of the TSX’s valuation.

Pent-up demand should result in a surge in economic activity in the second half of 2021, according to Mike Archibald, a portfolio manager at AGF Investments.

“Energy demand should return to more normal levels, helping the Canadian energy sector, and improving activity should result in better conditions for the Canadian banks,” he said.

Story continues below advertisement

The TSX is expected to end 2020 at 17,100, barely changed from its current level.

The index is less expensive than some others, with a higher weighting in technology or other sectors more favored by investors during the pandemic. Its price-to-earnings ratio is about 13, using forward-looking earnings estimates, compared to 22.4 for the S&P 500, I/B/E/S data from Refinitiv showed.

A slight majority of contributors forecast earnings would return roughly to pre-COVID-19 levels within a year or earlier.

“Rebounding corporate earnings, along with ongoing monetary policy stimulus and fiscal stimulus, will continue to provide broad support,” said Angelo Kourkafas, investment strategy analyst at Edward Jones.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies